Table 2.
Characteristics of anemia in CAD patients at study baseline
Reference | N | Severity at baseline, % (N) | Mean (SD) Hgb, g/dL | Median Hgb, g/dL | Range Hgb, g/dL | ||
---|---|---|---|---|---|---|---|
Severe | Moderate | Mild | |||||
This study* | 29 | 45 (13) | 34 (10) | 21 (6) | 8.3 (1.8) | 8.2 | 4.7-11.6 |
29* | 84 | 44 (37) | 32 (27) | 24 (20) | — | — | — |
28*,† | 15 | 84 (13) | 8 (1) | 8 (1) | — | 6.0 | — |
20 | 20 | 10 (2)‡ | 35 (7)‡ | 55 (11)‡ | 10.1 (1.8)‡ | 10.3 | 7.3-15.3 |
38 | 5 | 0 (0) | 60 (3) | 40 (2) | 10.5 (1.8)‡ | 9.8‡ | 8.4-12.5‡ |
10 | 14 | 21 (3)‡ | 50 (7)‡ | 29 (4)‡ | 9.3 (2.8)‡ | 9.1 | 4.0-15.0 |
40 | 9 | — | — | — | — | 9.4 | 7.1-12.2 |
39 | 14 | — | — | — | 9.4 (1.7) | — | — |
17 | 27 | — | — | — | 8.5 (NR)‡ | 8.2‡ | 6.2-12.3‡ |
11 | 86 | — | — | — | 9.2 (2.3) | 8.9 | 4.5-15.6 |
21 | 29 | — | — | — | — | 8.7 | 5.4-15.6 |
36 | 2 | — | — | — | — | — | 6.0-14.5 |
34 | 18 | — | — | — | — | 8.4 | 4.5-13.5 |
27 | 48 | — | — | — | — | 9.3 | 4.0-16.2 |
33 | 2 | — | — | — | 5.8 (0.4)‡ | 5.8‡ | 5.5-6.1‡ |
30 | 5 | — | — | — | 7.9 (3.0)‡ | 6.9‡ | 4.8-12.7‡ |
16 | 89 | — | — | — | — | 10.2 | 6.2-17.7 |
—, no data available; Hgb, hemoglobin; NR, not reported.
Study baseline is at disease onset.
Only percentages presented in the publication. Numbers of patients are calculated.
Calculated from raw data presented in text.